Ms. Mona Frendo at the Industry, Science and Technology Committee

On November 1st, 2010. See this statement in context.

November 1st, 2010 / 12:05 p.m.

Director, Patent and Trade-mark Policy Directorate, Department of Industry

Yes, if you read clauses 9 and 10 of Bill C-393 together, they would allow a CAMR authorization holder to produce and export the drugs authorized in the application indefinitely. That is the consequence of clauses 9 and 10 read together, because there would be no limit to the duration of a CAMR authorization and no need for renewal because it would be indefinite.

See context to find out what was said next.